tradingkey.logo

Envoy Medical Inc

COCH
0.733USD
+0.033+4.67%
收盤 12/19, 16:00美東報價延遲15分鐘
17.45M總市值
虧損本益比TTM

Envoy Medical Inc

0.733
+0.033+4.67%

關於 Envoy Medical Inc 公司

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Envoy Medical Inc簡介

公司代碼COCH
公司名稱Envoy Medical Inc
上市日期Mar 02, 2021
CEOLucas (Brent T)
員工數量42
證券類型Ordinary Share
年結日Mar 02
公司地址4875 White Bear Parkway
城市WHITE BEAR LAKE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編55110
電話16513618000
網址https://www.envoymedical.com/
公司代碼COCH
上市日期Mar 02, 2021
CEOLucas (Brent T)

Envoy Medical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月25日 週二
更新時間: 11月25日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.18%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.82%
其他
59.48%
持股股東
持股股東
佔比
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.18%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.82%
其他
59.48%
股東類型
持股股東
佔比
Individual Investor
37.08%
Investment Advisor
3.33%
Private Equity
1.93%
Investment Advisor/Hedge Fund
1.27%
Hedge Fund
1.23%
Research Firm
0.06%
其他
55.09%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
47
2.25M
9.80%
+81.14K
2025Q3
59
2.17M
17.45%
-288.93K
2025Q2
64
2.46M
24.39%
+3.06K
2025Q1
70
2.46M
24.73%
-2.82M
2024Q4
143
2.12M
158.30%
+927.59K
2024Q3
151
1.20M
185.14%
-129.06K
2024Q2
157
1.33M
194.46%
+97.08K
2024Q1
156
1.23M
199.37%
-37.85M
2023Q4
150
1.71M
201.29%
-1.36M
2023Q3
149
3.06M
201.92%
-985.94K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Taylor (Glen A)
10.29M
46.98%
--
--
Apr 10, 2025
Atlas Merchant Capital LLC
555.53K
2.54%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
394.96K
1.8%
--
--
Jun 30, 2025
Weiss Asset Management
368.14K
1.68%
-19.82K
-5.11%
Jun 30, 2025
Lucas (Brent T)
209.46K
0.96%
+7.74K
+3.84%
May 30, 2025
Focus Partners Wealth, LLC
212.66K
0.97%
--
--
Jun 30, 2025
DSG Capital Advisors, LLC
163.64K
0.75%
--
--
Jun 30, 2025
Arcus Capital Partners, LLC
187.57K
0.86%
--
--
Jun 30, 2025
Meteora Capital LLC
108.51K
0.5%
--
--
Apr 10, 2025
Kantor (Susan J.)
77.89K
0.36%
--
--
Apr 10, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Envoy Medical Inc的前五大股東是誰?

Envoy Medical Inc的前五大股東如下:
Taylor (Glen A)
持有股份:10.29M
佔總股份比例:46.98%。
Atlas Merchant Capital LLC
持有股份:555.53K
佔總股份比例:2.54%。
The Vanguard Group, Inc.
持有股份:394.96K
佔總股份比例:1.80%。
Weiss Asset Management
持有股份:368.14K
佔總股份比例:1.68%。
Lucas (Brent T)
持有股份:209.46K
佔總股份比例:0.96%。

Envoy Medical Inc的前三大股東類型是什麼?

Envoy Medical Inc 的前三大股東類型分別是:
Taylor (Glen A)
Atlas Merchant Capital LLC
The Vanguard Group, Inc.

有多少機構持有Envoy Medical Inc(COCH)的股份?

截至2025Q4,共有47家機構持有Envoy Medical Inc的股份,合計持有的股份價值約為2.25M,占公司總股份的9.80% 。與2025Q3相比,機構持股有所增加,增幅為-7.65%。

哪個業務部門對Envoy Medical Inc的收入貢獻最大?

在--,--業務部門對Envoy Medical Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI